focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 516.00
Bid: 516.00
Ask: 518.00
Change: 1.00 (0.19%)
Spread: 2.00 (0.388%)
Open: 512.00
High: 518.00
Low: 512.00
Prev. Close: 515.00
CRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

29 Jul 2013 07:00

RNS Number : 3002K
Creston PLC
29 July 2013
 



29 July 2013

 

Creston plc

Interim Management Statement

 

Creston plc ('Creston' or the 'Group') (LSE: CRE), the digitally focused insight and communications group, announces its interim management statement for the period 1 April 2013 to date.

 

Trading update

In the three months to 30 June 2013 (the 'Period'), as expected, revenue is slightly lower than last year with like-for-like revenue 5 per cent lower largely due to the previously announced loss of a client in the Health division. New business activity, however, is currently ahead of expectations and we are encouraged by the potential for this to positively impact revenue in the remainder of the year.

 

Communications

The division's revenue is broadly flat compared with the same period last year. Alongside normal new business activity, there has been substantial time spent on pitching for ten different contracts for the Government Procurement Service. Of these the division has already been awarded a contract for integrated marketing services, which is one of only two such contracts commissioned so far by the Government in its main roster, and we anticipate hearing news of the other pitches in the coming weeks. In the Period, the division has been appointed by Reckitt Benckiser to manage digital activity across its UK brands, by Bentley to manage its events marketing activity, by Sony to manage public relations across its PlayStation brands and the launch of the PlayStation 4, and has also been appointed by Sainsbury's to its digital roster. The full revenue upside from the addition of these new clients will benefit the Group this year.

 

Health

Revenue growth from the Group's UK companies is continuing to replace revenue from Cooney/Waters' contract with Sanofi Pasteur, which came to an end in FY13. The division has reported the expected decline in like-for-like revenue during the first three months compared with the same period last year. With recent joint agency pitches and wins, such as the previously announced global appointment by Gilead Sciences, and international public relations contracts for clients Novartis and Takeda in the Period, the division is well-placed to take advantage of developments in the sector going forward and in particular the increasing demand for digital expertise.

 

Insight

The division has reported an increase in like-for-like revenue compared with the same period last year, highlighting the continued recovery and growth of the division. This has been driven by the additional revenue generated from using innovative research technologies and digital platforms for data collection.

 

Outlook

Although we remain cautious given the potential impact of on-going market volatility on our clients, the Board is pleased with the continuing level of client demand for the digital capabilities of the Group and the increasing focus on cross-agency pitches. We are encouraged by the recent new business wins and are confident that these, added to the continuing high level of new business pitch activity during the Period, will enable the Group to meet the Board's expectations for the full year.

 

Don Elgie, Group Chief Executive of Creston plc, said, "The IPA Bellwether Report on client sentiment towards increased marketing spend is the most encouraging for six years. At Creston we are seeing this being borne out by high levels of new business activity and while opportunities must always be converted, the level of pitching we are seeing is the highest I can remember. Based on our historic pitch to win ratio, we are confident that this will lead to further underlying growth in our client base."

 

 

For further information please contact:

 

Creston plc

+ 44 (0)20 7930 9757

 

Don Elgie, Group Chief Executive

 

 

Barrie Brien, COO/CFO

 

 

Pelham Bell Pottinger

+44 (0)20 7861 3232 

David Rydell/Elly Williamson/ Malika Shermatova

 

About Creston plc

Creston plc (LSE: CRE) is a digitally focused insight and communications group. The Group delivers a range of marketing services, including advertising, brand consultancy, CRM, digital and direct marketing, health communications, local marketing, market research, PR and social media marketing to a broad spectrum of blue-chip global clients. Our insight companies give us a real edge, providing the analytic intelligence to enable us to deliver original thinking that engages audiences, invites participation and influences future trends. www.creston.com

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEAKXKAEKDEFF
Date   Source Headline
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change
8th Nov 20237:00 amRNSThird Quarter 2023 Trading Update
26th Oct 20237:00 amRNSNotice of Q3 2023 Trading Update and Webcast
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20233:59 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSDirector/PDMR Shareholding
27th Jul 20235:20 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSConduit Interim Results 2023
25th Jul 20237:00 amRNSDirectorate Change
14th Jul 20232:55 pmRNSNotice of H1 2023 Results and Conference Call
22nd Jun 20237:00 amRNSNotice of IFRS 17 Briefing Call
15th Jun 20234:48 pmRNSHolding(s) in Company
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSTransfer of Treasury Shares
19th May 20234:56 pmRNSDirector/PDMR Shareholding
19th May 20237:00 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSResults of 2023 AGM
17th May 20237:00 amRNSFirst Quarter 2023 Trading Update
4th May 20234:20 pmRNSNotice of Q1 2023 Trading Update and Webcast
17th Apr 20232:09 pmRNSNotice of AGM
6th Apr 20232:50 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSHolding(s) in Company
7th Mar 20234:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:25 amRNSPublication of 2022 Annual Report and Accounts
22nd Feb 20237:00 amRNSYear ended 31 December 2022 Preliminary Results
17th Feb 20237:00 amRNSAppointment of Corporate Brokers
2nd Feb 20237:00 amRNSNotice of 2022 Results and Conference Call
25th Jan 20237:00 amRNSJanuary 2023 Renewals Trading Update
20th Jan 20232:00 pmRNSHolding(s) in Company
18th Jan 20237:00 amRNSNotice of 1 Jan 23 Renewals Trading Update Call
23rd Dec 20229:17 amRNSConduit Re welcomes AM Best affirming A- rating
20th Dec 20227:00 amRNSConduit Re welcomes AMBest affirmation of A rating
9th Nov 20227:00 amRNSThird Quarter 2022 Trading Update
3rd Nov 20227:00 amRNSNotice of Q3 2022 Trading Update
29th Sep 20225:23 pmRNSPurchase of Shares by Employee Benefit Trust
26th Sep 20221:36 pmRNSPurchase of Shares by Employee Benefit Trust
16th Sep 20225:40 pmRNSTransaction in Own Shares
7th Sep 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.